MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0013893
Heilsa Life Sciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.85 Lakh
▲ 166% YoY
Net loss · FY 2025
₹8.97 Cr
Latest filing
EBITDA · FY 2025
-₹4.2 Cr
Latest filing
Authorised capital
₹24 Cr
Registered with MCA
Paid-up capital
₹16 Cr
Issued & subscribed
Open charges
₹211.25 Cr
Satisfied ₹147 Cr
Company age
5 yrs
Est. 2021
Employees · EPFO
1
Provident fund records
About Heilsa Life Sciences Private Limited
Data last updated:
Heilsa Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2021PTC387167. Its GSTIN is 05AAFCH9638H1ZC (Uttarakhand).
The company has an authorised share capital of ₹24 Cr and a paid-up capital of ₹16 Cr. It is led by directors including Ruchir Gupta (Managing Director) and Puneet Kansal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No.404/65 Pragati Tower Rajendra Place, Delhi, India – 110008.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.85 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹8.97 Cr and EBITDA of -₹4.2 Cr.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: Heilsa Life Sciences. As per MCA filings, the company has open charges of ₹211.25 Cr and satisfied charges of ₹147 Cr on record.
Heilsa Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0013893). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website heilsalife.com.
Company details
CIN U24100DL2021PTC387167
Registration Number 387167
Incorporation Date 26 September 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 12 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0013893
Recognitions & Rankings of Heilsa Life Sciences
Contact details
Heilsa Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is heilsalife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No.404/65 Pragati Tower Rajendra Place, Delhi, India – 110008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Heilsa Life Sciences Private Limited, buy the company report.
Comprehensive company report
Heilsa Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Heilsa Life Sciences operates one associated brand: Heilsa Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacture and export of liquid injections in the pharmaceuticals sector. | heilsalife.com |
Business activity
The main business activity of Heilsa Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Heilsa Life Sciences Private Limited, buy the company report.
Financials of Heilsa Life Sciences Private Limited
FY 2025 filings availableHeilsa Life Sciences Private Limited reported revenue of ₹29.85 Lakh (up 166% YoY) for FY 2025.
Revenue · FY 2025
₹29.85 Lakh ▲ 166%
Net loss · FY 2025
₹8.97 Cr
EBITDA · FY 2025
-₹4.2 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 166%
EBITDA CAGR growth
3 years · compounded
▼ 772%
Revenue rose 166% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4.2 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹8.97 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Heilsa Life Sciences Private Limited, buy the company report.
Board of directors of Heilsa Life Sciences Private Limited
Heilsa Life Sciences has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Agarwal Also directs: Axa Parenterals Limited, Goldenyellow Paper LLP, Omanand Papers Private Limited and 1 more | Director | 26 Sep 2021 | 5 Years 0 Months | Current |
| Ruchir Gupta | Managing Director | 26 Sep 2021 | 5 Years 0 Months | Current |
| Puneet Kansal Also directs: Vaishno Fertilizer Private Limited, Axa Parenterals Limited | Whole-Time Director | 26 Sep 2021 | 5 Years 0 Months | Current |
| Vijay Sing Bhandari Also directs: Axa Parenterals Limited | Director | 16 Mar 2022 | 4 Years 7 Months | Current |
| Yasha Agarwal Also directs: Axa Parenterals Limited | Director | 25 Jan 2023 | 3 Years 8 Months | Current |
Auditor
Heilsa Life Sciences Private Limited is audited by A JAIN AGARWAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A JAIN AGARWAL & CO. | FY 2023 | 013330C |
Shareholding
The shareholding of Heilsa Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Heilsa Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹211.25 Cr
Satisfied charges
₹147 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2023 | 100810798 | Others | ₹147 Cr | Open | |
| 11 Mar 2022 | 100566475 | Others | ₹64.25 Cr | Open | |
| 11 Mar 2022 | 100566472 | Others | ₹147 Cr | Satisfied |
To see the full charge records of Heilsa Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Heilsa Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Heilsa Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Heilsa Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAFCH9638H1ZC | Uttarakhand | Active | 21 Oct 2021 |
To see the full GST registrations and return filing status of Heilsa Life Sciences Private Limited, buy the company report.
Recent activity
Heilsa Life Sciences Private Limited has 7 board changes on record since 2021: 6 appointments and 1 cessation. The latest: Yasha Agarwal was appointed as Director on 25 Jan 2023.
AGM
Heilsa Life Sciences Private Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records.
Filing
Heilsa Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others of Rs. 64.25 Cr registered on 11 Mar 2022 with Charge ID 100566475 was modified on 18 Dec 2024.
Charges
A charge with Others of Rs. 147.00 Cr registered on 13 Oct 2023 with Charge ID 100810798 was modified on 16 Dec 2024.
Charges
A charge registered on 11 Mar 2022 via Charge ID 100566472 with Others was fully satisfied on 03 Nov 2023.
Charges
A charge with Others amounted to Rs. 147.00 Cr with Charge ID 100810798 was registered on 13 Oct 2023.
Appointed
Yasha Agarwal was appointed as Director.
Ceased
Manoj Agarwal ceased to be Director.
Appointed
Vijay Sing Bhandari was appointed as Director.
Charges
A charge with Others amounted to Rs. 147.00 Cr with Charge ID 100566472 was registered on 11 Mar 2022.
Charges
A charge with Others amounted to Rs. 64.25 Cr with Charge ID 100566475 was registered on 11 Mar 2022.
Appointed
Manoj Agarwal was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Heilsa Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 September 2021 (5+ years old) and is registered under CIN U24100DL2021PTC387167.
Heilsa Life Sciences has 5 current directors:
- Ruchir Gupta - Managing Director
- Puneet Kansal - Whole-Time Director
- Sumit Agarwal - Director
- Vijay Sing Bhandari - Director
- Yasha Agarwal - Director
The latest financial statements of Heilsa Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Heilsa Life Sciences is 05AAFCH9638H1ZC, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Heilsa Life Sciences is U24100DL2021PTC387167. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heilsa Life Sciences was incorporated on 26 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Yasha Agarwal was appointed as Director on 25 Jan 2023. Manoj Agarwal ceased to be Director on 01 Jan 2023. Vijay Sing Bhandari was appointed as Director on 16 Mar 2022. Heilsa Life Sciences has 7 board changes on record in total.
Yes, Heilsa Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0013893).
Heilsa Life Sciences can be reached through the website heilsalife.com. Its registered office is in Delhi, India.
The registered office of Heilsa Life Sciences is at Flat No.40465 Pragati Tower Rajendra Place, Delhi, India – 110008.